Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mussini

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of Viral Hepatitis|October 31, 2013
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysisV Di Marco, L Covolo, V Calvaruso, et al.
Pulmonology|May 2, 2022
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort studyS Busani, I Coloretti, M Baciarello, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
HIV Medicine|May 15, 2013
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analoguesM M Santoro, C Sabin, F Forbici, et al.
HIV Medicine|October 23, 2015
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome StatementsC Mussini, A Antinori, S Bhagani, et al.
Infection|November 24, 2007
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backboneM Bongiovanni, N Gianotti, E Chiesa, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodiesM Collins, J M Michot, F X Danlos, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of Viral Hepatitis|October 31, 2013
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysisV Di Marco, L Covolo, V Calvaruso, et al.
Pulmonology|May 2, 2022
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort studyS Busani, I Coloretti, M Baciarello, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
HIV Medicine|May 15, 2013
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analoguesM M Santoro, C Sabin, F Forbici, et al.
HIV Medicine|October 23, 2015
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome StatementsC Mussini, A Antinori, S Bhagani, et al.
Infection|November 24, 2007
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backboneM Bongiovanni, N Gianotti, E Chiesa, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodiesM Collins, J M Michot, F X Danlos, et al.
Pageof 9